Patent ID: 7001917
Filing Date: 2006-02-21
Classification: A61P,C07D

Abstract:
1. A compound of the following formula (I): wherein: R R R R A represents an aryl group having from 6 to 10 carbon atoms; B represents an alkylene group having from 1 to 6 carbon atoms; X represents NH, N[(C said aryl groups have 6 to 14 carbon atoms; said aryl groups are unsubstituted or are substituted by at least one substituent selected from the group consisting of substituents α, defined below; said aralkyl groups are alkyl groups having from 1 to 6 carbon atoms and which are substituted by at least one aryl group as defined above; said substituents α are selected from the group consisting of an aryl group as defined above, hydroxy group, halogen atoms, alkyl group having from 1 to 6 carbon atoms, alkoxy group having from 1 to 6 carbon atoms, alkylthio group having from 1 to 6 carbon atoms, alkanoyl group having from 1 to 6 carbon atoms, alkanoylamino group having from 1 to 6 carbon atoms, alkanoylaminoalkyl group having from 1 to 6 carbon atoms in the alkanoyl and alkyl part, amino group, mono- or di-alkylamino group having from 1 to 6 carbon atoms, haloalkyl group having from 1 to 6 carbon atoms, haloalkoxy group having from 1 to 6 carbon atoms, carbamoyl group, cyano group, a hydroxyalkyl group having from 1 to 6 carbon atoms, alkylsufinyl group having from 1 to 6 carbon atoms, alkylsufonyl group having from 1 to 6 carbon atoms, aminoalkoxy group having from 1 to 6 carbon atoms, mono- or di-alkylaminoalkoxy group, the alkyl group(s) having from 1 to 6 carbon atoms in the alkyl and alkoxy part, alkylsulfonylamino group having from 1 to 6 carbon atoms and aminosulfonyl group; with the proviso that said aryl group in said substituents α are not substituted by an aryl group; or a pharmaceutically acceptable ester of such compound, or a pharmaceutically acceptable salt thereof.